当前位置: X-MOL 学术Lancet Diabetes Endocrinol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Cystic-fibrosis-related diabetes: time for oral drugs?
The Lancet Diabetes & Endocrinology ( IF 44.0 ) Pub Date : 2017-11-30 , DOI: 10.1016/s2213-8587(17)30407-2
Antoinette Moran

First page of articleCriteria for the diagnosis of types 1 and 2 diabetes are based on glucose thresholds and risk of microvascular complications. The aim of treatment is to reduce this risk by lowering glucose and associated HbA1c concentrations. The treatment of cystic-fibrosis-related diabetes has a different focus. The disease has a pattern similar to early type 1 diabetes, the so-called honeymoon phase, when insulin needs are low and diabetes is fairly easy to control. Residual insulin secretion is present, and microvascular complications are less frequent and severe.

中文翻译:

囊性纤维化相关的糖尿病:口服药物的时间?

文章首页诊断1型和2型糖尿病的标准基于葡萄糖阈值和微血管并发症的风险。治疗的目的是通过降低葡萄糖和相关的HbA 1c浓度来降低这种风险。与囊性纤维化相关的糖尿病的治疗具有不同的重点。这种疾病的模式类似于早期的1型糖尿病,即所谓的蜜月期,那时胰岛素的需求量很低,而且糖尿病很容易控制。存在残留的胰岛素分泌,并且微血管并发症的发生频率较低且严重。
更新日期:2018-01-24
down
wechat
bug